HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection | Zendy

Surender Khurana | Zendy; Philip J. Norris | Zendy; Michael P. Busch | Zendy; Barton F. Haynes | Zendy; Susan Park | Zendy; Pretty Sasono | Zendy; Koleka Mlisana | Zendy; Salim S. Abdool Karim | Zendy; Frederick Hecht | Zendy; Joseph Mulenga | Zendy; Elwyn Chomba | Zendy; Eric Hunter | Zendy; Susan Allen | Zendy; George J. Nemo | Zendy; Isaac R. RodriguezChavez | Zendy; Joseph B. Margolick | Zendy; Hana Golding | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HIV-Selectest Enzyme Immunoassay and Rapid Test: Ability To Detect Seroconversion following HIV-1 Infection

Author(s) -

Surender Khurana,

Philip J. Norris,

Michael P. Busch,

Barton F. Haynes,

Susan Park,

Pretty Sasono,

Koleka Mlisana,

Salim S. Abdool Karim,

Frederick Hecht,

Joseph Mulenga,

Elwyn Chomba,

Eric Hunter,

Susan Allen,

George J. Nemo,

Isaac R. RodriguezChavez,

Joseph B. Margolick,

Hana Golding

Publication year - 2009

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.01573-09

Subject(s) - immunoassay , seroconversion , gp41 , human immunodeficiency virus (hiv) , virology , antibody , medicine , immunology , viral disease , immunopathology , epitope

HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research